Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pippa Corrie

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 30, 2020
The concepts of rechallenge and retreatment in melanoma: A proposal for consensus definitionsChristoffer Gebhardt, Paolo Ascierto, Victoria Atkinson, et al.
Oncology|September 16, 2015
Safety and Efficacy of Modified FOLFIRINOX for Advanced Pancreatic Adenocarcinoma: A UK Single-Centre ExperienceEhsan Ghorani, Han Hsi Wong, Carole Hewitt, et al.
International Journal of Cancer|August 25, 2020
Metastatic melanoma patient outcomes since introduction of immune checkpoint inhibitors in England between 2014 and 2018Ruth Board, Rebecca Smittenaar, Sarah Lawton, et al.
Chronic Illness|November 17, 2021
Burden of cancer trial participation: A qualitative sub-study of the INTERIM feasibility RCTChidiebere Nwolise, Pippa Corrie, Ray Fitzpatrick, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
A Modeling Study of the Cost-Effectiveness of a Risk-Stratified Surveillance Program for Melanoma in the United KingdomEdward C F Wilson, Juliet A Usher-Smith, Jon Emery, et al.
Cancer Treatment Reviews|September 13, 2022
Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysisPippa Corrie, Nicolas Meyer, Rossana Berardi, et al.
BMC Cancer|January 17, 2020
Early relapse on adjuvant gemcitabine associated with an exceptional response to 2nd line capecitabine chemotherapy in a patient with pancreatic adenosquamous carcinoma with strong intra-tumoural expression of cytidine deaminase: a case reportClaire M Connell, Rebecca Brais, Hayley Whitaker, et al.
Investigational New Drugs|March 5, 2013
An open-label study of the safety and tolerability of pazopanib in combination with FOLFOX6 or CapeOx in patients with colorectal cancerJoanne Brady, Pippa Corrie, Ian Chau, et al.
Investigational New Drugs|February 25, 2010
A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junctionJuan W Valle, Anne Armstrong, Chris Newman, et al.
BMC Cancer|January 20, 2025
Study protocol: multi-centre, randomised controlled clinical trial exploring stromal targeting in locally advanced pancreatic cancer; STARPAC2Hemant M Kocher, , , et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|August 30, 2020
The concepts of rechallenge and retreatment in melanoma: A proposal for consensus definitionsChristoffer Gebhardt, Paolo Ascierto, Victoria Atkinson, et al.
Oncology|September 16, 2015
Safety and Efficacy of Modified FOLFIRINOX for Advanced Pancreatic Adenocarcinoma: A UK Single-Centre ExperienceEhsan Ghorani, Han Hsi Wong, Carole Hewitt, et al.
International Journal of Cancer|August 25, 2020
Metastatic melanoma patient outcomes since introduction of immune checkpoint inhibitors in England between 2014 and 2018Ruth Board, Rebecca Smittenaar, Sarah Lawton, et al.
Chronic Illness|November 17, 2021
Burden of cancer trial participation: A qualitative sub-study of the INTERIM feasibility RCTChidiebere Nwolise, Pippa Corrie, Ray Fitzpatrick, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
A Modeling Study of the Cost-Effectiveness of a Risk-Stratified Surveillance Program for Melanoma in the United KingdomEdward C F Wilson, Juliet A Usher-Smith, Jon Emery, et al.
Cancer Treatment Reviews|September 13, 2022
Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysisPippa Corrie, Nicolas Meyer, Rossana Berardi, et al.
BMC Cancer|January 17, 2020
Early relapse on adjuvant gemcitabine associated with an exceptional response to 2nd line capecitabine chemotherapy in a patient with pancreatic adenosquamous carcinoma with strong intra-tumoural expression of cytidine deaminase: a case reportClaire M Connell, Rebecca Brais, Hayley Whitaker, et al.
Investigational New Drugs|March 5, 2013
An open-label study of the safety and tolerability of pazopanib in combination with FOLFOX6 or CapeOx in patients with colorectal cancerJoanne Brady, Pippa Corrie, Ian Chau, et al.
Investigational New Drugs|February 25, 2010
A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junctionJuan W Valle, Anne Armstrong, Chris Newman, et al.
BMC Cancer|January 20, 2025
Study protocol: multi-centre, randomised controlled clinical trial exploring stromal targeting in locally advanced pancreatic cancer; STARPAC2Hemant M Kocher, , , et al.
Pageof 6